xoma corp said file registr statement with secur and exchang commiss cover propos public offer mln common share xoma biotechnolog compani which produc monoclon antibodi base product treat some form cancer said proceed will use fund research and product develop human clinic trial and expans manufactur capac and work capit said dillon read and inc and alex brown and son inc will manag underwrit reuter 